FDA Inspection 1327690 — Vincas Urbonas, M.D., Ph.D. M.Sc.
The FDA completed an inspection of Vincas Urbonas, M.D., Ph.D. M.Sc. on Jul 2, 2026 in Vilniaus. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 2, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Vilniaus (Lithuania)
Additional Details
Clinical BA/BE